- CA$42.18m
- CA$35.95m
- CA$37.42m
- 98
- 78
- 39
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.28 | ||
| PEG Ratio (f) | 0.29 | ||
| EPS Growth (f) | 39.29% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.94 | ||
| Price to Tang. Book | 3.94 | ||
| Price to Free Cashflow | 10.28 | ||
| Price to Sales | 1.16 | ||
| EV to EBITDA | 8.06 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 29.3% | ||
| Return on Equity | 30.33% | ||
| Operating Margin | 10.83% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 24.38 | 24.48 | 28.86 | 25.17 | 37.42 | 36.4 | 48.3 | 12.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +78.26 | +24.18 | +33.6 | +38.84 | +3.59 | +70 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). It operates through one reportable segment, which involves the manufacture and sale of pollution control systems. Its solutions include BASYS and BiofiltAIR biofilter, MYTILUS biotrickling filter, multi-stage SYNERGY system, biogas desulfurization, dry scrubber adsorption systems and cannabis odor control. Its BASYS and BiofiltAIR biofilter systems are suited for odor control applications, especially when removing reduced sulfur compounds or VOCs. It offers biofiltration medias, which include BIOSORBENS, XLD, BIOPAK and BIOROLL & BIOBLOK. Its service solutions include system upgrades, preventative maintenance, and replacement and spare parts. Its other services include dispersion modeling, permit applications and community outreach programs.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- December 18th, 2003
- Public Since
- April 23rd, 2004
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
TSX Venture Exchange- Shares in Issue
- 18,582,000
- Address
- 7496 Wellington Rd. 34, R.R. #3, GUELPH, N1H 6H9
- Web
- https://www.biorem.biz/
- Phone
- +1 5197679100
- Auditors
- MNP LLP
Upcoming Events for BRM
Q3 2025 Biorem Inc Earnings Release
Similar to BRM
Avante
TSX Venture Exchange
BluMetric Environmental
TSX Venture Exchange
BQE Water
TSX Venture Exchange
Carrier Connect Data Solutions
TSX Venture Exchange
CHAR Technologies
TSX Venture Exchange
FAQ
What is the Biorem share price?
As of Today at 19:36 UTC, shares in Biorem are trading at CA$2.27. This share price information is delayed by 15 minutes.
How has the Biorem share price performed this year?
Shares in Biorem last closed at CA$2.27 and the price had moved by +14.49% over the past 365 days. In terms of relative price strength the Biorem share price has underperformed the Toronto Stock Exchange 300 Composite Index by -3.94% over the past year.
What are the analyst and broker recommendations for Biorem?
The overall consensus recommendation for Biorem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Biorem dividend yield?
Biorem does not currently pay a dividend.
Does Biorem pay a dividend?
Biorem does not currently pay a dividend.
When does Biorem next pay dividends?
Biorem does not currently pay a dividend.
How do I buy Biorem shares?
To buy shares in Biorem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biorem?
As of the previous close price of CA$2.27, shares in Biorem had a market capitalisation of CA$42.18m.
Where are Biorem shares listed?
Here are the trading details for Biorem:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: BRM
What kind of share is Biorem?
Based on an overall assessment of its quality, value and momentum Biorem is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biorem share price forecast for 2025?
The analyst consensus target price for shares in Biorem is CA$4.00. That is 76.21% above the last closing price of CA$2.27.
Analysts covering Biorem currently have a consensus Earnings Per Share (EPS) forecast of CA$0.20 for the next financial year.
Find out moreWhat is the trend in the Biorem share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biorem. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -29.91%.
As of the last closing price of CA$2.27, shares in Biorem were trading -9.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biorem PE Ratio?
The Biorem PE ratio based on its reported earnings over the past 12 months is 8.28. The shares last closed at CA$2.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biorem?
Biorem's management team is headed by:
- Derek Webb - PRE
- Douglas Newman - CFO
- Alex Gill - IND
- William White - IND